IndraLab

Statements

P38 inhibits USP22. 1 / 1

| 1

reach

"Treatment of human cervical carcinoma (HeLa) cells with SB203580, an inhibitor of p38 MAPK, enhanced basal USP22 promoter activity and mRNA abundance."

26171149

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

P38 inhibits USP22. 1 / 1

INDRA sources:

Databases

Reading